|
|
|
Insider
Information: |
Bohlin Garen G |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
303,864 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,932,342 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
303,864 |
|
|
Total
Value |
$1,932,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-9.9%
|
-2.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acusphere Inc |
ACUSD |
Director |
2009-01-02 |
152,944 |
2009-01-02 |
0 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
2017-11-14 |
53,312 |
2017-11-10 |
0 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
52,468 |
2018-05-24 |
0 |
Premium* |
|
Karyopharm Therapeutics Inc. |
KPTI |
|
2023-09-12 |
45,140 |
2021-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
COLL |
Collegium Pharmaceutical,... |
Director |
|
2024-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,693 |
52,468 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2024-05-14 |
4 |
S |
$32.30 |
$936,311 |
D/D |
(28,985) |
44,775 |
0 |
% |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2024-05-14 |
4 |
OE |
$5.73 |
$166,084 |
D/D |
28,985 |
73,760 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
|
|
2023-09-12 |
4 |
B |
$1.22 |
$49,985 |
D/D |
41,140 |
45,140 |
0.01 |
% |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,792 |
44,775 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,035 |
34,983 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,941 |
20,948 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2021-05-06 |
4 |
B |
$7.82 |
$31,280 |
D/D |
4,000 |
4,000 |
2.39 |
% |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,047 |
11,007 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,707 |
6,960 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
Director |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,253 |
2,253 |
0 |
- |
|
TARA |
Protara Therapeutics, Inc |
Director |
|
2017-11-14 |
4 |
A |
$1.89 |
$7,201 |
D/D |
3,812 |
53,312 |
0 |
- |
|
TARA |
Protara Therapeutics, Inc |
Director |
|
2017-11-13 |
4 |
A |
$1.92 |
$49,293 |
D/D |
25,700 |
49,500 |
0 |
- |
|
TARA |
Protara Therapeutics, Inc |
Director |
|
2017-11-10 |
4 |
A |
$1.96 |
$46,719 |
D/D |
23,800 |
23,800 |
0 |
- |
|
ACUSD |
Acusphere Inc |
Director |
|
2009-01-02 |
4 |
A |
$0.08 |
$7,500 |
D/D |
94,937 |
152,944 |
0 |
- |
|
ACUSD |
Acusphere Inc |
Director |
|
2008-10-01 |
4 |
A |
$0.43 |
$7,500 |
D/D |
17,442 |
58,007 |
0 |
- |
|
ACUSD |
Acusphere Inc |
Director |
|
2008-07-01 |
4 |
A |
$0.71 |
$7,500 |
D/D |
10,565 |
40,565 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|